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The multicenter Nephrotic Syndrome Study Network (NEPTUNE) digital pathology scoring 
system employs a novel and comprehensive methodology to document pathologic features from 
whole-slide images, immunofluorescence and ultrastructural digital images. To estimate inter- and 
intra-reader concordance of this descriptor-based approach, data from 12 pathologists (eight 
NEPTUNE and four non-NEPTUNE) with experience from training to 30 years were collected. A 
descriptor reference manual was generated and a webinar-based protocol for consensus/cross-
training implemented. Intra-reader concordance for 51 glomerular descriptors was evaluated on 
jpeg images by seven NEPTUNE pathologists scoring 131 glomeruli three times (Tests I, II, and 
III), each test following a consensus webinar review. Inter-reader concordance of glomerular 
descriptors was evaluated in 315 glomeruli by all pathologists; interstitial fibrosis and tubular 
atrophy (244 cases, whole-slide images) and four ultrastructural podocyte descriptors (178 cases, 
jpeg images) were evaluated once by six and five pathologists, respectively. Cohen’s kappa for 
inter-reader concordance for 48/51 glomerular descriptors with sufficient observations was 
moderate (0.40<kappa ≤0.60) for 17 and good (0.60<kappa ≤0.80) for 8, for 52% with moderate 
or better kappas. Clustering of glomerular descriptors based on similar pathologic features 
improved concordance. Concordance was independent of years of experience, and increased with 
webinar cross-training. Excellent concordance was achieved for interstitial fibrosis and tubular 
atrophy. Moderate-to-excellent concordance was achieved for all ultrastructural podocyte 
descriptors, with good-to-excellent concordance for descriptors commonly used in clinical 
practice, foot process effacement, and microvillous transformation. NEPTUNE digital pathology 
scoring system enables novel morphologic profiling of renal structures. For all histologic and 
ultrastructural descriptors tested with sufficient observations, moderate-to-excellent concordance 
was seen for 31/54 (57%). Descriptors not sufficiently represented will require further testing. This 
study proffers the NEPTUNE digital pathology scoring system as a model for standardization of 
renal biopsy interpretation extendable outside the NEPTUNE consortium, enabling international 
collaborations.
The challenge of inter-reader concordance on individual morphologic features of diagnostic 
renal biopsies is well documented and is highlighted in large collaborative studies.1–5 As the 
complexity of morphologic characterization and the number of features increase, it becomes 
more difficult to ensure intra- and inter-reader concordance. As one feature may show poor 
performance, a related and potential surrogate feature may show excellent performance and 
thus be preferable for routine diagnostic use. In the future, conventional interpretative 
diagnoses may be revised to include combined morphologic and molecular signatures.1,6,7 
With these changes in the pathology practice, it is important to assess the performance of 
individual metrics. The past approach has been to develop metrics that demonstrate high 
intra-pathologist concordance and high to good inter-pathologist concordance.
The availability of digital whole-slide images allows nephropathologists to overcome 
limitations of conventional light microscopy analysis, and to address concordance.8,9 Recent 
studies have demonstrated the high concordance and reliability of whole-slide images 
compared with conventional light microscopy evaluation for diagnoses of renal allograft 
rejection, as well as for individual Banff morphologic criteria.10,11 Morphologic analysis of 
annotated peritubular capillaries on whole-slide images in Fabry’s disease suggests that by 
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preselecting specific structures to be scored, achievable only by digital imaging, 
concordance is increased.12
The multicenter Nephrotic Syndrome Study Network (NEPTUNE) exemplifies a new model 
of systematic digital pathology review. The NEPTUNE Digital Pathology Protocol 
documents the whole-slide images-based scoring protocol, including selection of specific 
structures (eg, glomeruli) and the application of the NEPTUNE Digital Pathology Scoring 
System for comprehensive scoring of glo-merular, vascular and tubulointerstitial 
morphologic features (descriptors).13,14
This study aimed to assess inter- and intra-reader concordance, and the effect of consensus 
review and training sessions on the NEPTUNE Digital Pathology Scoring System. The 
ultimate goal is to establish new models for standardization of renal biopsy morphologic 
profiling, and to test validated descriptors as potential predictors of diagnosis, prognosis, and 
response to treatment.
Materials and methods
Digital Infrastructure
Pathology material was obtained from the NEPTUNE Digital Pathology Repository, where 
whole-slide images (from glass slides scanned at 40 × on Hamamtsu and Aperio scanners), 
immunofluorescence, electron microscopy (EM) images, electronic copies of de-identified 
original pathology reports from cases of focal segmental glomerulosclerosis, minimal 
change disease, and membranous nephropathy are stored.15,13
Preparation and Training for Scoring
Descriptor reference manual and image library—A reference manual was generated 
and refined by webinar consensus meetings by NEPTUNE pathologists (Supplementary 
Figure 1). Descriptors were evaluated for clarity prior to initiation of the concordance tests. 
The manual was posted in the NEPTUNE digital pathology repository (see Table 1 for 
descriptors used in this study and Supplementary Table 6 for the comprehensive descriptor 
reference manual). A library of representative images was created and posted in the 
NEPTUNE digital pathology repository for independent review prior to initiation of the 
study, and then removed during the trial.
Electronic scoring documents, material, and test instructions—Separate 
electronic scoring templates were generated for tubulointerstitial, ultrastructural, and 
glomerular scoring. The electronic matrix templates were pre-populated with ‘0’ (absent) 
scoring, so reviewers needed only to select descriptors applicable to a given case/image; 
semiquantitative or quantitative scores required clicking on a dropdown list. For better 
visualization, the color of the selected cell automatically changed when a value other than 0 
was selected (‘0’ = blue to ‘1’ = red) (Supplementary Figure 2).
For glomerular scoring, electronic scoring templates included the list of glomeruli, and jpeg 
images of glomeruli were provided to all pathologists. Separate electronic scoring sheets 
with the lists of cases to access in the NEPTUNE digital pathology repository were provided 
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to test tubulointerstitial descriptors such as interstitial fibrosis/tubular atrophy and 
ultrastructural podocyte features. Specific instructions for each of the metrics were made 
available. Training for data entry on the electronic scoring sheets was done during webinar 
meetings prior to the concordance tests.
Concordance Study Protocol
Image selection—For glomerular histologic descriptors, jpeg (joint photographic experts 
group) images (stained with hematoxilin and eosin, periodic acid Shift, trichrome, and 
silver) were obtained from both annotated whole-slide images from the NEPTUNE digital 
pathology repository and images previously used in a concordance study for the Columbia 
classification.16 For tubulointerstitial and ultrastructural podocyte descriptors, whole-slide 
images and EM jpeg images stored in the NEPTUNE digital pathology repository were 
used. All images were from previously anonymized whole-slide images or EM digital 
images collected in the NEPTUNE digital pathology repository following Institutional 
Review Board guidelines and upon approval in each participating center.
A total of 315 images of glomeruli were hand selected based on quality of the image and 
representation of descriptors; these images included classic examples as well as more 
controversial lesions. Interstitial fibrosis and tubular atrophy scoring was tested on whole-
slide images from 244 cases including minimal change disease, focal segmental 
glomerulosclerosis, and membranous nephropathy and podocyte descriptors on 178 
ultrastructural images (minimum of five EM images/case) from the minimal change disease/
focal segmental glomerulosclerosis cohort.
Participating pathologists—Twelve pathologists participated in the scoring, including 
eight NEPTUNE pathologists (P1–8, seven of whom participated in glomerular scoring, five 
in interstitial fibrosis and tubular atrophy scoring, and five in podocyte scoring) and four 
pathologists recruited outside the NEPTUNE consortium (non-NEPTUNE pathologists) 
(P9–12, of whom three participated in glomerular scoring and one in interstitial fibrosis and 
tubular atrophy scoring). The level of experience varied between fellowship level (P7 and 
P9) to >10 years of experience in renal pathology (Supplementary Table 1).
Glomerular descriptor concordance tests—To assess intra- and inter-reader 
concordance and the effect of cross-training/consensus review on inter-reader concordance, 
131 images of glomeruli were scored three times (Test I, II, and III) by seven NEPTUNE 
pathologists (Supplementary Figure 1). Webinar reviews occurred 2–4 weeks after each test. 
Washout intervals between tests varied from 2.5 to 4 months. To increase the number of 
inter-reader observations, 184 additional images were added to Test II for NEPTUNE 
pathologists. The 315 images were also scored once by three non-NEPTUNE pathologists 
who had one webinar training session. Images of the 131 glomeruli for Tests I and III and 
315 glomeruli for Test II were reviewed during consensus webinar meetings to increase 
concordance in descriptor recognition.
Intra-reader concordance of glomerular descriptors was estimated by comparing each 
pathologist’s scores from Test I vs Test II and Test II vs Test III. These estimates of 
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concordance may be reduced as a result of webinar training; ie, gained knowledge about 
scoring may reduce consistency with previous scoring.
Inter-reader concordance of descriptors was estimated separately for each Test (I, II, and III), 
and involved computing concordance for each pair of pathologists, and pooling these 
estimates over all possible pairs. In addition to the overall estimate of inter-reader 
concordance, we were interested in four research questions: (a) whether continuous cross-
training improved concordance, (b) whether concordance differed by the pathologist’s 
experience, (c) whether concordance was higher using clusters of descriptors sharing similar 
features than for individual descriptors, and (d) whether concordance was maintained 
outside the NEPTUNE investigators.
Tubulointerstitial descriptor concordance tests—To test concordance of non-
glomerular parameters, we considered the most clinically relevant tubulointer-stitial 
parameters,17–22 the percentage (0–100%) of cortex involved by interstitial fibrosis and 
tubular atrophy, for 244 cases. Conventional pathology practice includes semiquantitative 
assessment of interstitial fibrosis and tubular atrophy. Therefore, interstitial fibrosis and 
tubular atrophy scoring was not preceded by webinar training and was performed only once 
by six pathologists.
Podocyte descriptor concordance tests—Although ultrastructural evaluation of 
podocyte morphology is common in pathology practice, estimates of some ultrastructural 
parameters are often not reported. Thus, the podocyte descriptor test was preceded by a 
webinar session to review definitions reflecting effacement, condensation of actin-based 
cytoskeleton, microvillous transformation, and loss of primary processes. Ultrastructural 
podocyte descriptors were scored by five pathologists with 1 to >10 years of experience on 
178 cases (minimal change disease/focal segmental glomerulosclerosis) as follows: foot 
process effacement: 0 = 1–10%, 1+ = 11–25%, 2+ = 26–50%, 3+ = 51–75%, and 4+ = 
>75%; condensation of actin-based cytoskeleton and microvillous transformation: 0 = not 
observed, 1+ = segmental (≤50%), 2+ = global (>50%); loss of primary processes was 
scored as absent (0) or present (1+).
Statistical Methods
For the (dichotomous) glomerular descriptors, intra-reader agreement was assessed by both 
Cohen’s kappa and pathologist-specific counts of the number of descriptors that the 
pathologist rated the same way in two consecutive readings. Inter-reader agreement between 
pairs of pathologists was also estimated using Cohen’s kappa, but Fleiss’ kappa23 was used 
to estimate inter-reader agreement pooled across all pathologists. The variability in kappa 
values across pairs of pathologists for each descriptor is shown using boxplots.
Scoring was also performed for clusters of glomerular descriptors sharing morphologic 
similarities. A cluster was judged to be present if at least one descriptor of the cluster was 
present, and Fleiss’ kappa was used to assess pooled inter-reader agreement among 
pathologists. The kappa statistic ranges from − 1 (perfect disagreement) to 1 (perfect 
agreement), with a value of 0 indicating agreement expected by chance alone. Kappa 
statistics were categorized and interpreted as: >0.80 (excellent); 0.61–0.80 (good); 0.41–0.60 
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(moderate); 0.21–0.40 (fair); 0–0.20 (poor); and <0 (no agreement) (http://healthcare-
economist.com/2011/11/02/kappa-statistic). Because kappa is smaller with lower prevalence 
of the finding under observation, we report the range over pathologists of the number of 
glomeruli in which each descriptor was observed. Although we calculated kappa statistics 
for all descriptors with at least one pathologist rating, some results exclude descriptors with 
insufficient observations, defined as the maximum over all pathologists of the number of 
glomeruli in which the descriptor was observed being less than five.
We investigated the four research questions listed above as follows: (a) to assess whether 
inter-reader concordance could improve with cross-training we evaluated the number of 
descriptors that increased in concordance between Tests I and II, and between Tests I and III; 
(b) to assess whether inter-reader concordance depended on the pathologist’s years of 
experience, we compared the kappas from all pathologists with the kappas excluding the 
trainees; (c) to assess the effect of scoring descriptor clusters, we visually compared cluster 
concordance with individual concordance estimates for each descriptor in the cluster; and d) 
to assess whether concordance was maintained outside NEPTUNE investigators we 
compared concordance among the three non-NEPTUNE pathologists and among the seven 
NEP-TUNE pathologists using the 315 glomerular images from Test II. The Neptune and 
non-Neptune summary kappas were compared by paired t-test.
For the continuous interstitial fibrosis and tubular atrophy scores, inter-reader agreement was 
estimated using Pearson’s correlation coefficient on all pairs of pathologists (the pathologist 
with more vs less years of experience). For the ordinal podocyte descriptors, Kendall’s 
coefficient of concordance was used to assess inter-reader agreement for pairs of 
pathologists.
Results
Intra-reader Concordance for Glomerular Descriptors
When comparing glomerular intra-reader concordance Test I vs Test II and Test II vs Test 
III, the average intra-reader concordance for glomerular descriptors increased with cross-
training/consensus webinars. (Supplementary Table 2 and Supplementary Table 3). When 
comparing glomerular concordance Test II versus Test III, there were four descriptors for 
which all pairs of readers had good concordance, and 11 descriptors where all pairs had at 
least moderate concordance (Supplementary Table 3). Interestingly, inconsistent intra-reader 
concordance was noted for lesions of segmental sclerosis corresponding to ‘perihilar’ and 
‘not otherwise specified’ variants of the Columbia classification.24 At least moderate intra-
reader agreement was found for most of the descriptors commonly associated with 
segmental sclerosis or collapse, such as various form of hyalinosis, podocyte hypertrophy, 
foam cells or peri-glomerular fibrosis. Unexpected inconsistency in intra-reader agreement 
was noted for basic lesions such as global sclerosis, although other forms of global damage 
(obsolescence, global collapse, deflation and spikes) were more consistently recognized.
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Inter-reader Concordance for Glomerular Descriptors
For the 315 glomeruli (Test II), 48/51 glomerular descriptors had sufficient data for 
evaluation. The kappa statistics from the combined NEPTUNE and non-NEPTUNE 
pathologists represent our current best summaries of this investigation. Based on these 
results, 8/48 descriptors had good inter-reader concordance; these included descriptors 
indicating global lesions (global spikes, deflation, collapse, and obsolescence) and 
segmental lesions (foam cells, cellular tip lesion, segmental deflation necrosis). An 
additional 17/48 descriptors had moderate concordance for a total of 52% of descriptors 
tested having an inter-reader Cohen’s kappa ≥ 0.40 (Table 3). Concordance between pairs of 
pathologists varied widely by pair and by descriptor, but most had moderate or better 
concordance (Figure 1a and b).
The overall inter-reader concordance increased with cross-training from Test I through Test 
III among NEPTUNE pathologists in the set of 131 glomerular images. Of the 51 glomerular 
descriptors tested, 19 were not sufficiently represented to evaluate inter-reader concordance. 
For 32 descriptors with sufficient data for comparison, 56% had improved kappas between 
Tests I and II, and 63% between Tests I and III. Five descriptors improved the initial kappas 
of moderate to good or excellent, including global lesions (such as global deflation), 
segmental lesions (mid-glomerular segmental sclerosis and hyalinosis at the vascular pole), 
and the descriptor indicating no abnormalities. An additional three descriptors (cellular non-
tip lesions, periglomerular fibrosis, and global podocyte hyper-plasia) increased performance 
from fair/poor to moderate or good. (Table 1, Table 2, Figure 1a and b).
As expected, better concordance was achieved in most cases by clustering descriptors 
together. Compared with the cluster kappas, most component kappas are substantially 
smaller. However, for five of the clusters, a single component kappa was larger than the 
cluster kappa, showing that clustering often, but not always, leads to optimum concordance. 
Concordance improved when selected descriptors for sclerosing/obliterating lesions or for 
epithelial cell (podocytes) damage were combined (Table 3).
Concordance was independent of years of experience; analysis excluding the data generated 
by the trainees did not change significantly the overall concordance (data not shown). 
NEPTUNE and non-NEPTUNE pathologists had comparable overall inter-reader kappas 
(mean difference between kappas = 0.015, paired t-test P = 0.502).
Inter-reader Concordance for Tubulointerstitial Parameters
Excellent concordance was seen for both interstitial fibrosis and tubular atrophy, 
independent of years of experience (Figure 2; Figure 3d and e; Supplementary Table 4). In 
addition, overall concordance for interstitial fibrosis and tubular atrophy scoring remained 
consistently excellent when analyzed separately for each disease (minimal change disease, 
focal segmental glomerulosclerosis, and membranous nephropathy; data not shown).
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Inter-reader Concordance for Podocyte Descriptors
Concordance was excellent for foot process effacement and good for microvillous 
transformation and condensation of the actin cytoskeleton, and moderate for loss of primary 
processes. (Figures 3f–i and 4; Supplementary Table 5).
Descriptor Reference Manual Revision
At the end of the study the descriptor reference manual was revised during several consensus 
webinar sessions that included NEPTUNE pathologists as well as pathologists outside the 
consortium, and language was added to improve clarity of definitions (Supplementary Table 
6).
Discussion
To take advantage of and coordinate with new findings being discovered in molecular 
nephrology, renal pathologists must identify methodologies and approaches that allow for 
better integration of morphologic evaluation creating more compelling diagnostic 
paradigms.14 Furthermore, it is critical to design and implement classification systems for 
clinical research that are more meaningful with regard to novel renal biomarkers, prognosis, 
and treatment approaches.1 The use of such morphologic observations requires concordance 
of pathologic analysis across diseases, level of training and experience. One goal of the 
NEPTUNE consortium is to identify reproducible morphologic variables that can be 
implemented in clinical practice by creating a new taxonomy of renal diseases. Toward that 
goal, we carried out a study testing intra- and inter-pathologist concordance using a set of 51 
glomerular, two tubulointerstitial and four ultra-structural features.
The first critical step toward a robust morphologic evaluation was the establishment of well 
defined morphologic criteria documented in a reference manual. The NEPTUNE digital 
pathology scoring system reference manual is comprehensive of features included by other 
classification systems and we referred to previously published criteria for some of the 
descriptors;5,25 however, many of the descriptors listed in the NEPTUNE digital pathology 
scoring system, although used in clinical practice to some degree, were not thoroughly 
defined by consensus and organized in a comprehensive reference manual prior this study.
An innovative contribution of this study is the development of a protocol exploiting digital 
pathology technology. The introduction of digital pathology into large-scale glomerular 
disease research has enabled simultaneous remote access of multiple users.1,11,13,17,26,27 The 
application of digital technology, and of software for annotation of glomeruli, offers the 
opportunity to systematically eliminate glomerular selection bias, providing the basis for 
potentially higher inter-observer concordance.12 Although it is intuitive that there are 
minimal differences in concordance when scoring interstitial fibrosis and tubular atrophy by 
conventional light microscopy or whole-slide images, recognizing the value of specifically 
selecting structures to be evaluated, a recent concordance study was conducted using single 
digital images of glomeruli to identify the five patterns of focal segmental 
glomerulosclerosis (Columbia classification). This strategy, eliminating the glomerular 
selection bias, resulted in an overall good agreement among the six pathologists.16 In our 
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study, we partially mimic the strategy utilized by Meehan et al16 by capturing digital images 
of individual annotated glomeruli from the whole-slide images of the 400 cases stored in the 
NEPTUNE digital pathology repository. By controlling the modality of the image review, 
the observations made, while under the control of the pathologist, were consistent with 
regard to image quality and to some extent magnification between reviewers. Using this 
approach, we were able to apply an ‘object oriented’ evaluation of performance, rather than 
a specimen-based approach.
Concordance of individual descriptors and factors contributing to concordance: most 
concordance studies are based on a one-time assessment. In our study, we demonstrated that 
concordance is modifiable by cross-training over time. This approach was tested in a study 
on thymic epithelial neoplasms, and resulted in post-webinar training improved 
concordance, confirming the value of digital pathology as an educational tool.27 Although 
the inter-reader discrepancies in our study may appear significant, the total number of 
parameters involved for which pathologists needed cross-training, compared with a single 
diagnosis of epithelial neoplasia in the Wang’s study, was much greater. Intra-reader 
concordance also improved with cross-training and webinar-based consensus as more 
detailed and objective criteria were provided to the participants, lessening individual 
reluctance in changing internal/subjective criteria. Thus, we still consider our observations 
encouraging for the systematic application of webinar cross-training to increase intra- and 
inter-reader concordance.
The best performance was obtained by the interstitial fibrosis and tubular atrophy score, with 
overall excellent inter-reader concordance despite the lack of previous webinar training. 
Similar high concordance was obtained in the Oxford classification study.5 We hypothesize 
that this excellent performance is a consequence of the routine scoring of interstitial fibrosis 
and tubular atrophy in renal biopsy practice. Similarly, concordance was proportional to the 
frequency the ultrastructural podocyte descriptors are used in routine renal pathology 
assessment of biopsies; the highest concordance was recorded for the most commonly used 
parameter (foot process effacement) and the lowest for the descriptor used only 
experimentally (loss of primary process).28 These data raise the question of whether 
descriptors for which familiarity and training are inadequate should be used and included in 
future studies. Developing robust training tools and metrics of performance is critical, as 
these infrequently assessed lesions may demonstrate correlation with clinical or molecular 
parameters and may add value to morphologic analysis or classifications. The continuous 
cross-training approach may ultimately prevent future classification systems from excluding 
morphologic criteria initially not performing well, but that may still have great potential as 
predictors of outcome. This concept may alter the current approach to generating 
classifications, which currently select for morphologic features based on concordance, to 
including initially less reproducible but valuable observational data by introducing post-
training amendment and adjustment options. Should this occur, greater use of such features 
in routine clinical practice would then increase familiarity and automatically improve 
concordance.
The uneven level of concordance of some glomerular histologic descriptors is not easily 
explained. Although we eliminated the glomerular selection bias and provided a prefilled 
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electronic scoring sheet listing all possible descriptors, lack of reproducibility for some 
descriptors may derive by failure to see or forgetting to mark a specific lesion among others 
affecting the same glomerulus, whereas for descriptors that are present in isolation, such as 
global spikes, it may have been easier to maintain the focus. Whereas global collapse or 
capillary wall spikes had expected high concordance, variable concordance was observed for 
subtypes of global or segmental sclerosis, although when consolidated under global or 
segmental obliteration, overall performance increased. The high concordance of segmental 
obliteration as an overall category confirms the data obtained by the Oxford classification 
study, where segmental sclerosis was defined as solidification/obliteration involving any part 
of the tuft and not broken down in subtypes based on location or cellularity.5 The lack of 
consistency in recognizing the type of segmental sclerosis may appear to challenge the value 
of the conventional classification system of focal segmental glomerulosclerosis.25 While low 
concordance is experienced when using individual descriptors defining the subtypes of 
segmental sclerosis, the application of the Columbia classification system at the glomerular 
level may have better concordance.16 The paradox that summary diagnostic approaches, 
rather than lesion-driven diagnostic paradigms, have better performance in concordance 
studies suggest that pathologists are using the totality of the histopathology to arrive at a 
diagnosis. This ‘holistic’ approach may be diagnostically powerful, but may limit prognostic 
utility, which is better elucidated by feature-based criteria. In addition, although all 
participants recognized epithelial cell (podocyte) injury, there were features that were 
inconsistently identified across reviewers, with the greatest difficulty in differentiating 
segmental vs global lesions and hyperplasia vs hypertrophy. When segmental and global or 
hypertrophy and hyperplasia were combined, concordance increased. Good concordance 
was obtained by combining all podocyte abnormalities. It also appeared that the challenge in 
identifying segmental vs global lesions is not limited to podocytes but also applicable to 
mesangial cell proliferation. Again, by combining segmental and global mesangial cell 
proliferation, the kappa coefficient increased in the 315 glomeruli study to 0.64, confirming 
that the overall mesangial cell proliferation has adequate concordance to be included in 
classification systems.5 The poor concordance of these features suggests that they require 
additional refinement and evaluation before inclusion in classification systems where, for 
example, the recognition of segmental vs global damage/proliferation may drive therapeutic 
choices.29 Additional studies, currently in process, have been developed with the goals of (a) 
re-testing this approach provided more training, (b) testing reproducibility in the context of a 
European-based (EURenOmics) and Chinese-based (NEPTUNE-China) study by a different 
set of reviewing pathologists applying the NEPTUNE digital pathology scoring system, (c) 
testing all NEPTUNE descriptors using different metrics (for example continuous vs 
dichotomous), and (d) applying other statistical methods.
When comparing data from NEPTUNE pathologists after several training sessions to non-
NEPTUNE pathologists, the overall concordance was in favor of the NEPTUNE 
pathologists, although on 315 glomeruli the number of descriptors with a good or excellent 
concordance was greater for non-NEPTUNE pathologists. Several factors may have 
contributed to this result, including variability among pathologists.
This study also addressed whether concordance depended on years of experience in clinical 
practice. The overall coefficient of concordance did not change with the exclusion of 
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pathologists in training. Trainees are accustomed to individual feature recognition as part of 
the learning process compared to experienced pathologists who are used to pattern 
recognition summarizing individual features into a diagnosis line.
After post-study revision of the reference manual to add clarity to the descriptor definitions 
(Supplementary Table 6), the NEPTUNE digital pathology scoring system and protocol were 
shared and implemented by other multicenter consortia with the generation of an 
INTEGRATE (INTErnational diGital nephRopAThology nEtwork) between pathologists 
from North America (NEPTUNE), Europe (EURenOmics) and Asia (China-DiKip).
In conclusion, the NEPTUNE digital pathology scoring system provides comprehensive 
analysis of renal structures with good-to-excellent concordance for many parameters. 
Although previous classification systems have eliminated poorly performing descriptors,5 
here we provide an alternative model that maintains the original scoring metrics, but applies 
summary measures of clustered features and recommends continuing cross/training and 
consensus meetings. As metrics should ultimately be measured against their contribution to 
outcome and to guiding therapy, the rationale in favor of improving performance in contrast 
to dropping descriptors is that these descriptors have potential for important clinical value. 
Thus, this novel protocol for continuous improvement may serve as a model with potential 
to modify current classification systems, applicable across multiple international consortia, 
enabling world-wide collaboration and compilation of permanently recordable granular 
observational data suitable for correlation with clinical and molecular profiling of 
glomerular diseases.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
For each of 51 descriptors, an inter-reader kappa statistic was calculated for each of the 45 
pairs of 10 pathologists. The boxplots show the distributions of these sets of 45 kappa 
statistics. (a) glomerular descriptors indicating sclerosis or associated with sclerosis.29 (b) 
All other glomerular descriptors.22
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Figure 2. 
For each of the interstitial fibrosis and tubular atrophy descriptors, Pearson correlation 
coefficients were calculated for all 10 pairs of 5 pathologists on 244 cases. The boxplots 
show the distributions of these sets of correlation coefficients.
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Figure 3. 
Glomerular and tubulointerstitial histologic descriptors: (a) A segmental obliteration of the 
glomerular tuft at the tip of the glomerulus is here represented. Additional descriptors 
applicable to this glomerular image are segmental epithelial cell hypertrophy, halo, adhesion, 
and global mesangial cell hypercellularity (Hematoxilin & Eosin). (b) The glomerulus here 
represented is morphologically profiled by segmental epithelial cell (podocyte) hypertrophy 
and hyperplasia, hyaline droplets and segmental collapse (Silver). (c) Foam cells, adhesion 
and hyalinosis are noted in the absence of increase matrix (sclerosis) (Hematoxilin & Eosin). 
(d) Trichrome stain showing increased deposition of collagen in between the tubules 
(interstitial fibrosis) and thickening on the tubular basement membranes in atrophic tubules 
(tubular atrophy). (e) Trichrome stain showing small tubules with thickened tubular 
basement membranes lined by small cuboidal epithelial cells. Ultrastructural Podocyte 
descriptors. (f) In this electron micrograph there is extensive foot process effacement with 
loss or widening of individual foot processes. (g) Aberrant formation of numerous slender 
cellular projections resembling microvilli or vesicle-like structures is seen along the apical 
surface of podocytes. (h) Condensation of electron-dense filaments against the sole of 
podocytes is present. (i) Loss of primary processes was recorded when epithelial (podocyte) 
cell bodies were in direct contact with glomerular basement membranes without 
interposition of primary processes.
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Figure 4. 
For each of the podocyte descriptors, pairwise Kendall’s coefficient of concordance was 
calculated for all 10 pairs of five pathologists on 178 cases. The boxplots show the 
distributions of these sets of correlation coefficients.
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Table 1
Post study revised definitions of descriptors included in the current study
WSI histology
 Glomerular damage
  Glomerular descriptors listed below are scored as present (1) or absent (0).
  No (minimal) changes: none of the lesions below is present.
  Global sclerosis with hyalinosis: sclerosis involves 100% of the glomerular tuft glomerular size is preserved, or compared with the 
glomeruli obtained in the same biopsy, increased or decreased by not >50%.
  Global sclerosis without hyalinosis: sclerosis involves 100% of the glomerular tuft, with no accompanying hyalinosis. Glomerular size is 
preserved, or compared with the glomeruli obtained in the same biopsy, increased or decreased by not >50%.
  Global deflation: global wrinkling and folding of the GBM (≥80% of the tuft) without epithelial cell (podocyte) hypertrophy and 
hyperplasia (formerly known an ischemic type of collapse). The urinary space is patent. The wrinkling is generally made by small regular folds 
of the GBM.
  Global capillary collapse: wrinkling and folding of the GBM involving ≥80% of the tuft with occlusion or subocclusion of capillary 
lumina. Collapse is generally accompanied by hypertrophy and hyperplasia of overlying epithelial cells (pseudo-crescents). Epithelial cell 
(podocyte) hypertrophy and hyperplasia if present are marked separately as individual descriptors. The wrinkling is generally made by small 
and/or big irregular folds of the GBM.
  Obsolescent glomeruli: glomeruli are small and globally sclerotic without hyalinosis. Bowman’s capsule is completely or partially absent 
and there is no periglomerular fibrosis. Obsolescent glomeruli are defined when glomerular size is decreased >50% compared with all other 
glomeruli in the same biopsy.
  Global mesangial sclerosis: a generalized global increase (100%) of mesangial matrix is present with or without mesangial cell 
hypercellularity and hypertrophy of overlying epithelial cells (podocytes).
  Segmental perihilar sclerosis (vascular pole): segmental solidification of the glomerular tuft is present with increased extracellular 
matrix in continuity with the vascular pole. If hyalinosis, foam cells, hypertrophy of overlying epithelial cells (podocytes), halo and adhesion of 
the tuft to the Bowman’s capsule is present, they should be marked as separate descriptors.
  Extended segmental perihilar sclerosis (vascular pole): segmental solidification of the glomerular tuft with increased extracellular 
matrix in continuity with the vascular pole and extends beyond the middle line of the tuft, with or without involving the tip. If hyalinosis, foam 
cells, hypertrophy of overlying epithelial cells (podocytes), halo and synechia/adhesion of the tuft to the Bowman’s capsule is present, they 
should be marked as separate descriptors. (This lesion includes segmental solidification known as ‘approaching’ global sclerosis).
  Segmental sclerosis away from vascular and tubular poles: segmental solidification of the tuft with increased extracellular matrix. If 
hyalinosis, foam cells, hypertrophy of overlying epithelial cells (podocytes), halo and adhesion of the tuft to the Bowman’s capsule is present, 
these features should be marked as separate descriptors.
  Segmental sclerosis cannot determine location: None of the above. Vascular or tubular pole cannot be seen in section. If hyalinosis, foam 
cells, hypertrophy of overlying epithelial cells (podocytes), halo and adhesion of the tuft to the Bowman’s capsule is present, they should be 
marked as separate descriptors.
  Cellular tip lesion: foam cells with or without other intracapillary cells within the glomerular tuft at the tubular pole, accompanied by 
hypertrophy of glomerular epithelial cells (podocytes) exclusive of tubular epithelium, and/or bridging to the Bowman’s capsule/proximal 
tubule take off area. The presence of foam cells or inflammatory cells needs to be marked separately as individual descriptors when present.
  Sclerosing tip lesion: solidification of the tuft at the tubular pole with increased extracellular matrix with or without adhesion to 
Bowman’s capsule. Glomerular epithelial cells (podocytes) may be hypertrophic and attached to the epithelium at the tubular pole.
  Extended cellular tip lesion: foam cells with or without other intracapillary cells within the glomerular tuft at the tubular pole. The 
process extends through a large portion of the glomerulus (>1/2 of the tuft) but does not involve the vascular pole, accompanied by hypertrophy 
of epithelial cells (podocytes) and/or bridging to the Bowman’s capsule/proximal tubule take off area. The presence of foam cells or 
inflammatory cells needs to be marked separately as individual descriptors when present. (This lesion includes segmental solidification not 
involving the vascular pole but ‘approaching’ global sclerosis).
  Extended sclerosing tip lesion: solidification of the tuft at the tubular pole with increased extracellular matrix and adhesion to Bowman’s 
capsule, which extends through a large portion of the glomerulus but does not involve the vascular pole. No foam cells are present. Glomerular 
epithelial cells (podocytes) are hypertrophic and attached to epithelial cells at the tubular pole. (This lesion includes segmental solidification not 
involving the vascular pole but ‘approaching’ global sclerosis).
  Mid-tuft/central location of segmental sclerosis: located neither at the tip, the perihilum, or the periphery of the tuft (no adhesion to the 
Bowman’s capsule).
  Cellular lesions—non-tip: endocapillary hypercellularity with epithelial cell (podocyte) hypertrophy. Hypercellularity may be due to 
foam cells and/or endocapillary cells with or without karyhorrexis and is not at the tip of the glomerulus. The presence of foam cells, 
karyhorrexis, or inflammatory cells need to be marked separately as individual descriptors when present.
  Segmental capillary collapse: wrinkling and folding of the GBM involving at least one glomerular lobule and <80% of the tuft, with 
occlusion or subocclusion of capillary lumina. Collapse is generally accompanied by hypertrophy and hyperplasia of overlying epithelial cells 
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(podocytes); epithelial cell (podocyte) hypertrophy and hyperplasia if present need to be marked separately as individual descriptors. The 
wrinkling is generally made by small and/or big irregular folds of the GBM.
  Segmental deflation: wrinkling and folding of the capillaries without epithelial cell (podocyte) hyperplasia (formerly called ischemic type 
of collapse) involving <80% of the glomerular tuft. The wrinkling is generally made by small regular folds of the GBM.
  Periglomerular fibrosis: circumferential fibrosis in the interstitium surrounding the Bowman’s capsule.
  Glomerular foam cells: intracapillary foam cells in the presence or absence of segmental or global sclerosis.
  Hyaline droplets in epithelial cell (podocyte): protein droplets are present in glomerular epithelial cells (podocytes). These cells usually 
are also hypertrophic (if so, both descriptors apply).
  Hyalinosis at the vascular pole: hyalinosis is defined as glassy acidophilic, PAS-positive, silver-negative material.
  Hyalinosis at the tubular pole: hyalinosis is defined as glassy acidophilic, PAS-positive, silver-negative material. Solidification of the tuft 
and/or foam cells may be present.
  Hyalinosis away from the vascular and tubular poles: hyalinosis is defined as glassy acidophilic, PAS-positive, silver-negative material. 
Both the vascular and the tubular pole are present in the glomerular cross-section.
  Hyalinosis cannot determine location: hyalinosis is defined as glassy acidophilic, PAS-positive, silver-negative material and can occur 
with or without adhesion to the Bowman’s capsule in a location that is not the vascular pole of the tip of the glomerulus. The vascular and/or the 
tubular poles cannot be identified.
  Synechiae: continuity of glomerular tuft basement membrane to the Bowman’s capsule with continuity of epithelial cell lining. Note: a 
synechia generally includes 1–2 capillaries at the most and it may or may not be associated with segmental sclerosis, hyalinosis or foam cells. 
Larger adhering section of the glomerular tuft to the Bowman’s capsule in the presence of significant hyalinosis and/or sclerosis is not 
considered a synechia but an adhesion part of the segmental sclerosis.
  Segmental epithelial cell (podocyte) hypertrophy: hypertrophy is defined as enlarged cytoplasm or enlarged nuclei with prominent 
nucleoli or both. Segmental hypertrophy is defined when enlarged epithelial cells (podocytes) overlying the GBM involve <50% of the 
glomerular tuft.
  Global epithelial cell (podocyte) hypertrophy: hypertrophy is defined as enlarged cytoplasm or enlarged nuclei with prominent nucleoli 
or both. Global hypertrophy is defined when enlarged epithelial cells (podocytes) overlying the GBM involve ≥50% of the glomerular tuft.
  Segmental epithelial cell (podocyte) hyperplasia: ≥ 2 layers of epithelial cells (podocytes) overlying the GBM are present, involving 
<50% of the glomerulus. Hyperplasia may occur with or without hypertrophy.
  Global epithelial cell (podocyte) hyperplasia: ≥ 2 layers of epithelial cells (podocytes) overlying the GBM are present, involving ≥ 50% 
of the glomerulus. Hyperplasia may occur with or without hypertrophy.
  Halo (detachment of overlaying podocytes): detachment of epithelial cells (podocytes) from original underlying GBM is present with 
intervening new loose basement membrane material (pale on HE, PAS, trichrome, or silver stain).
  Segmental mesangial hypercellularity: >3 mesangial cells per mesangial lobule involving <50% of the visible mesangial regions in a 
glomerulus.
  Global mesangial hypercellularity: >3 mesangial cells per mesangial lobule involving ≥ 50% of the visible mesangial regions in a 
glomerulus.
  Segmental presence of spikes on silver stain: spikes are defined as silver positive stain with an irregular profile on the outer side of the 
GBM and involving <50% of the glomeruli.
  Global presence of spikes on silver stain: spikes are defined as silver positive stains with an irregular profile on the outer side of the 
GBM involving ≥ 50% of the glomerulus.
  Infiltrating leukocytes: the presence of leukocytes in glomerular capillaries is recorded when ≥ 1 inflammatory cell is present in capillary 
lumina.
  Segmental endocapillary hypercellularity: hypercellularity owing to increased number of cells within glomerular capillary lumina 
causing narrowing of the lumina involving <50% of the glomerulus.
  Global endocapillary hypercellularity: hypercellularity owing to increased number of cells within glomerular capillary lumina causing 
narrowing of the lumina involving >50% of the glomerulus.
  Segmental GBM Duplication: is defined as a double contour of the GBM involving <50% of the glomerular tuft, with or without 
endocapillary hypercellularity (endocapillary hypercellularity is independent variable).
  Global GBM duplication: is defined as a double contour of the GBM involving >50% of the glomerular tuft, with or without 
endocapillary hypercellularity (endocapillary hypercellularity is independent variable).
  Segmental increased mesangial matrix: Defined as an increase in the extracellular material in the mesangium such that the width of the 
interspace exceeds two mesangial cell nuclei in at least one glomerular lobule but <50% of the glomerular tuft.
  Global increased mesangial matrix: defined as an increase in the extracellular material in the mesangium such that the width of the 
interspace exceeds two mesangial cell nuclei in ≥ 50% of the glomerular tuft.
  Karyorrhexis: presence of apoptotic, pyknotic, and/or fragmented nuclei.
  Necrosis: defined as disruption of the GBM with fibrin exudation and karyorrhexis.
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  Very segmental extracapillary cellular proliferation (cellular crescent): extracapillary cell proliferation of >2 cell layers with >50% of 
the lesion occupied by cells, involving <25% of the Bowman’s space.
  Very segmental extracapillary fibrocellular proliferation (fibrocellular crescent): defined as part of the circumference of Bowman’s 
capsule covered by a combination of cells and extracellular matrix, with <50% cells and <90% matrix involving <25% of the Bowman’s space. 
This lesion is often associated with disruption of Bowman’s capsule. Ischemic, obsolescent glomeruli should be excluded.
  Very segmental extracapillary fibrosis (fibrous crescent): defined as >10% of the circumference of Bowman’s capsule covered by a 
lesion composed of >90% extracellular matrix involving <25% of the Bowman’s space.
  Extensive extracapillary cellular proliferation (cellular crescent): extracapillary cell proliferation of more than two cell layers with 
>50% of the lesion occupied by cells, involving >25% of the Bowman’s space.
  Extensive extracapillary fibrocellular proliferation (fibrocellular crescent): defined as part of the circumference of Bowman’s capsule 
covered by a combination of cells and extracellular matrix, with <50% cells and <90% matrix involving >25% of the Bowman’s space. This 
lesion is often associated with disruption of Bowman’s capsule. Ischemic, obsolescent glomeruli should be excluded.
  Extensive extracapillary fibrosis (fibrous crescent): defined as >10% of the circumference of Bowman’s capsule covered by a lesion 
composed of >90% extracellular matrix involving >25% of the Bowman’s space.
 Tubulointerstitial damage
  Tubular atrophy: small tubules with thick tubular basement membranes lined by small cuboidal or flat cells. Generally accompanied by 
fibrosis. Includes ‘thyroidization’ of the parenchyma. (0 = absent, 1 = present).
  Interstitial fibrosis: the interstitium is expanded by the presence of collagen that stain blue on trichrome. Tubules are not back to back, but 
rather separated by fibrosis and can be atrophic. (0 = absent, 1 = present).
 Electron microscopy
  A minimum of five electron micrographs are reviewed.
  Foot process effacement: Loss of foot processes. % of glomerular capillary surface area affected by effacement is recorded as a 
semiquantitative value. (0 = 0–10%; 1 = 11–25%; 2 = 26–50%; 3 = 51–75%; 4 = 76–100% of the outer GBM surface).
  Condensation of the actin-based cytoskeleton: electron-dense cytoskeleton is reorganized and condensed at the GBM aspect of epithelial 
cell (podocyte) foot processes. Percentage of glomerular capillary surface area affected by effacement is recorded as semiquantitative value. (0 = 
0–5%; 1 = ≤50%; 2 = >50% of the outer GBM surface).
  Microvillous transformation: cytoplasmic projections into the urinary space that emanate from the luminal side of epithelial cell 
(podocyte) membrane are present. Percentage of glomerular capillary surface area affected by effacement is recorded as semiquantitative value 
(0 = 0–5%; 1 = ≤50%; 2 = >50% of the outer GBM surface).
  Loss of primary processes: epithelial cell (podocyte) body sits directly on underlying GBM. This is generally accompanied by complete 
effacement (loss of foot processes). It is recorded as present or absent (0 = present − normal; 1 = absent − loss).
GBM, Glomerular Basement Membranes.
Note: The Kappa values are included in the Tables and Supplementary Tables for each descriptor.
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Table 3
Inter-reader agreement (Cohen’s kappa) of NEPTUNE pathologists for clusters of glomerular descriptors 
assessed in Test I, II, and III (131 glomeruli)
Clusters of Glomerular Descriptors Test I Kappa Test II Kappa Test III Kappa Cluster Component Kappas (Test III)
Global obliteration a 0.79 0.76 0.83 0.60, 0.22, 0.79, 0.85, 0.70
Segmental obliteration b 0.69 0.63 0.73
0.36, 0.28, 0.40, 0.57, 0.66, 
0.37, 0.03, 0.76, 0.63, 0.00, 
0.27, 0.55, 0.45
Collapse, segmental and global c 0.78 0.75 0.78 0.85, 0.37
Tip lesions, cellular and sclerosing d 0.76 0.70 0.77 0.69, 0.53, 0.00, 0.00
Hyalinosis (all locations) e 0.67 0.69 0.72 0.63, 0.00, 0.27, 0.55
Mesangial hypercellularity, segmental and global f 0.59 0.64 0.54 0.33, 0.44
Epithelial cell abnormalities g 0.70 0.58 0.66 0.51, 0.48, 0.63, 0.31, 0.61, 0.53
Epithelial cell hypertrophy, segmental and global h 0.66 0.64 0.60 0.48, 0.63
Epithelial cell hyperplasia, segmental and global i 0.44 0.47 0.42 0.31, 0.61
Segmental epithelial cell hypertrophy/hyperplasia j 0.48 0.48 0.52 0.48, 0.31
Global epithelial cell hypertrophy/hyperplasia k 0.60 0.64 0.67 0.63, 0.61
Each cluster is composed of descriptors sharing morphologic similarities, and was judged to be present if at least one descriptor of the cluster was 
identified as present. Kappa statistics for each component of each cluster are given in the last column; any component kappa larger than the Test III 
cluster kappa is shown in bold.
Clusters and corresponding descriptors:
aGlobal obliteration = global sclerosis with hyalinosis, global sclerosis without hyalinosis, global deflation, global collapse, obsolescent;
bSegmental obliteration = segmental perihilar sclerosis, segmental extended perihilar sclerosis, segmental sclerosis away from vascular and tubular 
pole, segmental sclerosis cannot determine location, mid-glomerular sclerosis, segmental collapse, segmental deflation, foam cells, hyalinosis at 
vascular pole, hyalinosis at tubular pole, hyalinosis away from vascular and tubular pole, hyalinosis cannot determine location, adhesion;
cCollapse, segmental, and global = global collapse, segmental collapse;
d
Tip lesions, cellular, and sclerosing = cellular tip lesion, sclerosing tip lesion, extended cellular tip lesion, extended sclerosing tip lesion;
e
Hyalinosis (all locations) = hyalinosis at vascular pole, hyalinosis at tubular pole, hyalinosis away from vascular and tubular pole, hyalinosis 
cannot determine location;
f
Mesangial hypercellularity, segmental, and global = segmental mesangial hypercellularity, global mesangial hypercellularity;
g
Epithelial cell abnormalities = hyaline droplets in epithelial cells (podocytes), Segmental epithelial cell (podocyte) hypertrophy, Global epithelial 
cell (podocyte) hypertrophy, Segmental epithelial cell (podocyte) hyperplasia, Global epithelial cell (podocyte) hyperplasia, Halo (detachment of 
podocytes);
h
Epithelial cell hypertrophy segmental and global = segmental epithelial cell (podocyte) hypertrophy, global epithelial cell (podocyte) hypertrophy;
i
Epithelial cell hyperplasia, segmental, and global = segmental epithelial cell (podocyte) hyperplasia, global epithelial cell (podocyte) hyperplasia;
jSegmental epithelial cell hypertrophy/hyperplasia = segmental epithelial cell (podocyte) hypertrophy, segmental epithelial cell (podocyte) 
hyperplasia;
kGlobal epithelial cell hypertrophy/hyperplasia = global epithelial cell (podocyte) hypertrophy, global epithelial cell (podocyte) hyperplasia.
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a–k
The descriptors associated with a cluster can be found in Table 2 as the descriptors with the same superscript as the cluster above.
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